Risks associated with being screened include finding abnormalities that need additional tests and that are ultimately benign. These tests can cause anxiety and on some occasions lead to invasive procedures such as biopsy to further determine whether a finding is a cancer. The I-ELCAP protocol has been frequently updated with the latest knowledge and advances to keep these risks at a minimum. This should be discussed with your doctor for further information.
Our events include the semi-annual International Conference on Screening for Lung Cancer, and CME training courses on CT screening for lung cancer and its related issues.